Moderna, an American biotechnology company, submitted an emergency use authorization (EUA) request to the US Food and Drug Administration (FDA) on Thursday for a fourth dose of its COVID-19 vaccine for adults 18 years and older who have already received a booster dose of any approved or authorised shot.
According to the company, the request to include adults over the age of 18 was made to give the US Centers for Disease Control and Prevention and healthcare providers more flexibility in “determining the appropriate use of an additional booster dose,” including for those at higher risk of COVID-19 due to age or comorbidities.
The FDA has approved a booster dose of the Moderna COVID-19 vaccine at a 50 microgram dosage level for emergency use in people 18 and older in the United States.
Moderna stated that real-world data on their COVID-19 vaccine is still being collected and monitored. Moderna’s Omicron-specific booster and a bivalent Omicron-specific booster are now undergoing clinical studies.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…